Combined Therapy with Levothyroxine and Liothyronine in Two Ratios, Compared with Levothyroxine Monotherapy in Primary Hypothyroidism: a Double-Blind, Randomized, Controlled Clinical Trial
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Controversy remains about the value of combined treatment with levothyroxine (LT4) and liothyronine (LT3), compared with LT4 alone in primary hypothyroidism. We compared combined treatment with LT4 and LT3 in a ratio of 5:1 or 10:1 with LT4 monotherapy. We conducted a double-blind, randomized, controlled trial in 141 patients (18-70 yr old) with primary autoimmune hypothyroidism, recruited via general practitioners. Inclusion criteria included: LT4 treatment for 6 months or more, a stable dose for 6 wk or more, and serum TSH levels between 0.11 and 4.0 microU/ml (mU/liter). Randomization groups were: 1) continuation of LT4 (n = 48); 2) LT4/LT3, ratio 10:1 (n = 46); and 3) LT4/LT3, ratio 5:1 (n = 47). Subjective preference of study medication after 15 wk, compared with usual LT4, was the primary outcome measure. Secondary outcomes included scores on questionnaires on mood, fatigue, psychological symptoms, and a substantial set of neurocognitive tests. Study medication was preferred to usual treatment by 29.2, 41.3, and 52.2% in the LT4, 10:1 ratio, and 5:1 ratio groups, respectively (chi2 test for trend, P = 0.024). This linear trend was not substantiated by results on any of the secondary outcome measures: scores on questionnaires and neurocognitive tests consistently ameliorated, but the amelioration was not different among the treatment groups. Median end point serum TSH was 0.64 microU/ml (mU/liter), 0.35 microU/ml (mU/liter), and 0.07 microU/ml (mU/liter), respectively [ANOVA on ln(TSH) for linear trend, P < 0.01]. Mean body weight change was +0.1, -0.5, and -1.7 kg, respectively (ANOVA for trend, P = 0.01). Decrease in weight, but not decrease in serum TSH was correlated with increased satisfaction with study medication. Of the patients who preferred combined LT4/LT3 therapy, 44% had serum TSH less than 0.11 microU/ml (mU/liter). Patients preferred combined LT4/LT3 therapy to usual LT4 therapy, but changes in mood, fatigue, well-being, and neurocognitive functions could not satisfactorily explain why the primary outcome was in favor of LT4/LT3 combination therapy. Decrease in body weight was associated with satisfaction with study medication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For the parallel design trials, there was a preference for combination therapy in one trial of 130 patients (53)”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [53]
In the citing paper
“In the LT4/LT3 study of Appelhof et al. (53), no significant change in the PRO used was seen, but patients more frequently expressed a preference for the combination.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [53]
In the citing paper
“This was not achieved in five trials, with two trials having a lower TSH in the combination therapy group (including the Appelhof trial in 5:1 ratio group) (53,71), and three trials having a higher serum TSH in the combination therapy group (47,52,58).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [53]
In the citing paper
“Eleven trials were 5–16 weeks (23,46,49,51–53,58–60,71,79), three trials were 4–6 months (17,48,78), and one trial was 1 year in duration (47).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [53]
In the citing paper
“Two trials showed a decreased cholesterol in the combination therapy arm (53,78), while a third trial showed an increased cholesterol in the combination therapy group, but this group also had a higher mean TSH value (52).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [53]
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Smets, E. M. A., Garssen, B., Bonke, B., & De Haes, J. C. J. M. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)00125-o · Cited by 3,613
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276 · cited 1×
“The set included the 32-item Profile of Mood States Dutch shortened version (POMS), designed to monitor changes in mood states (10); the original Dutch version of the Multidimensional Fatigue Inventory (MFI-20), consisting of 20 questions and designed to measure (changes in) fatigue (11); the mental health and vitalit…”
MethodWerner & Ingbar's the thyroid : a fundamental and clinical text
Werner, S. C., Ingbar, S. H., Braverman, L. E., & Utiger, R. D. (2012) · Lippincott-Raven eBooks · Cited by 1,016
Rivermead Behavioural Memory Test: Præsentation og vurdering af en ny psykologisk prøve
COUR, P. L., & GALLAGHER, K. (1990) · Nordisk Psykologi · doi:10.1080/00291463.1990.10636996 · Cited by 988
Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”
Braunholtz, D. A., Edwards, S. J. L., & Lilford, R. J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00305-x · Cited by 539
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 3×
“It has been noted before that many hypothyroid patients find their physicians to be unsympathetic and dismissive of their symptoms (1), which may explain the extent of these aspecific trial effects in this study investigating the possibility to relief these uncomprehended complaints.”
BackgroundInfluentialBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 2×
“5 g LT3 daily resulted in improved scores on mood scales and neurocognitive tests (4).”
BackgroundThe psychological effects of concussion
Gronwall, D., & Sampson, H. (1974) · Cited by 289
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
The Psychological Effects of Concussion
Walsh, K. W. (1975) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1975.tb106128.x · Cited by 285
Cited by
Items 101–198 of 198
Treatment Preferences in Patients With Hypothyroidism
de Lima Beltrão, F. E., Carvalhal, G., de Almeida Beltrão, D. C., de Lima Beltrão, F. E., Ribeiro, M. O., Ettleson, M. D., Ramos, H. E., & Bianco, A. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae651 · Cited by 16
Vargas‐Uricoechea, H., & Wartofsky, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179218 · Cited by 15
Latrofa, F., & Pinchera, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-517-6_7 · Cited by 15
Akçay, T., Turan, S., Güran, T., Ünlügüzel, G., Haklar, G., & Bereket, A. (2010) · Hormone Research in Paediatrics · doi:10.1159/000277627 · Cited by 15
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Mazzaferri, E. L. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70611-4 · Cited by 12
Bahl, S., Taylor, P. N., Premawardhana, L. D., Stedman, M., Heald, A., Dayan, C. M., & Okosieme, O. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf449 · Cited by 11
“We excluded Of the included studies, 18 trials contained information on the number of trial participants in each study arm who discontinued treatment or withdrew from trials due to AEs (54-70 , 73).”
The complexity of the relationship between thyroid disease and body weight
Jonklaas, J. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01190-0 · Cited by 10
Bjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Lee-Ødegård, S., Rangberg, A., Jonassen, C. M., Budge, H., Morris, D. E., Law, J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.785175 · Cited by 10
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism
Jonklaas, J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.003 · Cited by 10
Mazzaferri, E. L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70362-7 · Cited by 10
Triiodothyronine alongside levothyroxine in the management of hypothyroidism?
Gottwald-Hostalek, U., & Kahaly, G. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1984219 · Cited by 9
Mazza, A. D. (2025) · Cureus · doi:10.7759/cureus.90685 · Cited by 9
Phan, G. Q., Yavuz, S., Stamatouli, A. M., Madan, R., Chen, S., Grover, A. C., Nilubol, N., Bedoya, P., Trankle, C. R., Markley, R., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1522753 · Cited by 9
Antonelli, A., Fallahi, P., Bari, F. D., Giuggioli, D., Ferrari, S. M., & Ferri, C. (2017) · PubMed · Cited by 9
Metabolic Systemic Effects Triiodothyronine
Troshina, E. A., & Семеновна, С. Е. (2020) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2020-10-4-262-271 · Cited by 9
NHG-Standaard Schildklieraandoeningen
Wessels, P., van Rijswijk, E., Boer, M. A., & van Lieshout, J. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_86 · Cited by 9
Pappy, A. L., Oyesiku, N. M., & Ioachimescu, A. G. (2016) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709616661834 · Cited by 8
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Combined therapy with levothyroxine and liothyronine for hypothyroidism
Fischman, A., & Domínguez, J. M. (2018) · Medwave · doi:10.5867/medwave.2018.08.7375 · Cited by 7
Nice guideline on thyroid disease: where does it take us with liothyronine?
Leese, G. (2020) · Thyroid Research · doi:10.1186/s13044-020-00081-y · Cited by 7
Hughes, D. A., Skiadas, K., Fitzsimmons, D. F., Anderson, P., & Heald, A. H. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051702 · Cited by 7
Yokoya, M., & Higuchi, Y. (2016) · Journal of Circadian Rhythms · doi:10.5334/jcr.142 · Cited by 7
Pepper, G. M., & Casanova-Romero, P. Y. (2014) · Cited by 7
Gottwald-Hostalek, U., & Tayrouz, Y. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2435460 · Cited by 6
Guglielmi, R., Mian, C., Novizio, R., Paoletta, A., Persichetti, A., Samperi, I., Scoppola, A., Bagnasco, M., Menis, E. D., Rimini, M. L. D., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02652-y · Cited by 6
The Influence of Thyroid Dysfunction on Body Composition and Weight Trajectory
Jonklaas, J. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.11.012 · Cited by 6
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01434-y · Cited by 6
Lowe, J. C. (2009) · Cited by 6
Jonklaas, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_19 · Cited by 6
Alternative and Complementary Treatment of Thyroid Disorders
Onumah, B. M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3314-3_69 · Cited by 6
Potential uses of T3 in the treatment of human disease
Danzi, S. E., & Klein, I. L. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80052-3 · Cited by 6
Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey
Grixti, L., Fisher, H., Priestley, J., McMullan, C., Woollven, A., Perros, P., Mitchell, A. L., Gan, E. H., & Pearce, S. H. S. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0044 · Cited by 5
Heald, A. H., Livingston, M. A., & Hughes, D. A. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1062-6167 · Cited by 5
The Association of Thyroid Immunity with Blood Pressure and Body Mass Index in Primary Care Patients
Bunevičius, A., Pečeliūnienė, J., Mickuvienė, N., Girdler, S. S., & Bunevičius, R. (2008) · Endocrine Research · doi:10.1080/07435800802534126 · Cited by 5
Pinchera, A., & Santini, F. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0027 · Cited by 5
Acquired hypothyroidism after switching from thyroid USP to levothyroxine
Jellinger, P. S. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80055-9 · Cited by 4
Лечение первичного гипотиреоза: нерешенные вопросы
Моргунова, Т. Б., Madiyarova, M. S., & Fadeyev, V. V. (2015) · Clinical and experimental thyroidology · doi:10.14341/ket2015122-34 · Cited by 4
Kyriacou, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00005-1 · Cited by 4
Rethinking strategies for solving thyroid dysfunction at the heart of cardiovascular disease
Rajagopalan, V., Ojamaa, K., & Gerdes, A. M. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01351-x · Cited by 3
Bononi, M., Toma, G. D., Scarpini, M., Miccini, M., Cesare, A. D., Meucci, M., Bonapasta, S. A., Celotto, A., & Tocchi, A. (2010) · PubMed · Cited by 3
Eligar, V. S., Taylor, P. N., Okosieme, O. E., & Dayan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00077-8 · Cited by 3
Psychosocial Factors in Patients with Thyroid Disease
Mandincov, P. (2012) · InTech eBooks · doi:10.5772/36477 · Cited by 3
T3 and T4: Are we missing half the picture?
Klein, I. L. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80051-1 · Cited by 3
Quality of life in hypothyroid subjects treated with levothyroxine: a cross-sectional study
Rezaeizade, H., Shabestari, M., Hazar, N., Ghadiri‐Anari, A., Mehrali, M., Salehi‐Shadkami, M., & Azizi, R. (2026) · Thyroid Research · doi:10.1186/s13044-026-00307-5 · Cited by 2
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
L-T4 and L-T3 combined treatment vs L-T4 alone
Wiersinga, W. M. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.008 · Cited by 2
Self-citationStrategies for improved management of hypothyroidism
Hoang (2022) · The Journal of Family Practice · doi:10.12788/jfp.0378 · Cited by 2
Is euthyroidism within reach for all?
Jonklaas, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267120 · Cited by 2
Jonklaas, J. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2492789 · Cited by 2
Grabenstein, J. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80053-5 · Cited by 2
Shahbazi‐Gahrouei, D., Bonyadi, P., Moslehi, M., & Shahi, Z. (2008) · Iranian Journal of Nuclear Medicine · Cited by 2
McDermott, M., & Ridgway, E. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-5 · Cited by 4
Baron, H. L., & SINGER, P. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50042-1 · Cited by 2
Integrative Approaches to Patients Undergoing Thyroid Surgery
Olson, B. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-43618-0_23 · Cited by 2
Book Review: Ultra-Metabolism: The Simple Plan for Automatic Weight Loss
Bessesen, D. H. (2006) · Obesity Management · doi:10.1089/obe.2006.2.245 · Cited by 2
Mood, anxiety disorders and suicidal ideation in primary care patients
Pečeliūnienė, J. (2011) · Lithuanian University of Health Sciences · Cited by 2
Combination therapy rationale in the management of hypothyroidism
Gupta, M., Saraogi, H., & Dey, A. K. (2024) · Thyroid Research and Practice · doi:10.4103/trp.trp_35_24 · Cited by 1
Chen, J., Lin, Z., Luo, Y., Tang, H., Chen, F., Liu, P., & Huang, Y. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02085-x · Cited by 1
Evaluation of thyroxine resistance in patients with hypothyroidism: a laboratory study
Jasim, D. N., & Jaber, Z. A. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.8.2025.1652 · Cited by 1
Options of Replacement Therapy in Hypothyroidism
Valentine, V., Galina, A., & Morgunov, T. (2012) · InTech eBooks · doi:10.5772/31226 · Cited by 1
Terapia sostitutiva combinata con L-T4 e L-T3 nell’ipotiroidismo
Biondi, B., Celi, F. S., Duntas, L. H., Isidori, A. M., Pontecorvi, A., Salvatore, D., Vitti, P., & Trimarchi, F. (2015) · L Endocrinologo · doi:10.1007/s40619-015-0158-6 · Cited by 1
Combined l-thyroxine and l-triiodothyronine replacement therapy in congenital hypothyroidism
Peter, F., & Muzsnai, Á. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29599 · Cited by 1
Drug management of thyroid disorders in primary care
Weetman, A. P. (2006) · Prescriber · doi:10.1002/psb.338 · Cited by 1
Pidchenko, N. S. (2020) · Український радіологічний та онкологічний журнал · doi:10.46879/ukroj.4.2020.387-402 · Cited by 1
Essentials of Thyroid Hormone Treatment in Differentiated Thyroid Cancer
Aydoğan, B. İ., & Gürsoy, A. (2021) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2021.0002 · Cited by 1
Talay, G., & Türker, P. F. (2021) · Sağlık ve Yaşam Bilimleri Dergisi · doi:10.33308/2687248x.202132206 · Cited by 1
Sfeir, J. G., & Gharib, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_2 · Cited by 1
Hashimoto-Thyreoiditis: Mehr als nur Schilddrüsenhormonmangel?
Führer, D. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Bedecarratz, N. L. (2024) · UWA Profiles and Research Repository (UWA) · doi:10.26182/k555-qc54 · Cited by 1
Klawitter, B. (2006) · FreiDok plus (Universitätsbibliothek Freiburg) · Cited by 1
T4 versus T3 and T4: Is It a Real Controversy?
Weetman, A. P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097569
Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose?
Piantanida, E., Compri, E., Gandolfo, M., Sassi, L., Dionigi, G., Lai, A., Tanda, M. L., & Bartalena, L. (2009) · Current Cancer Therapy Reviews · doi:10.2174/157339409789712717
Is combination therapy appropriate for hypothyroidism?
Linder, L., & Clements, J. N. (2015) · JAAPA · doi:10.1097/01.jaa.0000470438.14941.98
Frafjord, H. (2008) · NORA - Norwegian Open Research Archives
Optimal Management of Hypothyroidism: Incremental Improvements for use in 2016 and Beyond
Hennessey, J. V. (2016) · Endocrine Practice · doi:10.4158/ep161586.co
Bahroo, S. L. (2016) · Physician Assistant Clinics · doi:10.1016/j.cpha.2016.08.006
Kant, R., & Verma, V. K. (2018) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000e127
Alternative and Complementary Support for People with Hypothyroidism
Norrgård, C. (2019) · Theseus (Ammattikorkeakoulujen)
Modalities of Thyroid Hormone Administration and Correlates Between Blood and Tissue Levels
Celi, F. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_26
Ajwah, I., Ajwah, A. M., Albalawi, H. M., Alsaqqa, E. M., Alshehri, M. A., Alnahyah, O. A., Alatawi, E. S., & Mirghani, H. O. (2020) · Australasian Medical Journal · doi:10.35841/1836-1935.13.3.86-91
NHG-Standaard Schildklieraandoeningen: Eerste herziening
Wessels, P., van Rijswijk, E., Boer, A., & van Lieshout, J. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_71
64 脳卒中片麻痺における,音刺激後の片脚挙上動作反応時間と歩行能力の関連性(神経系理学療法IV)
福井, 瑞., 久保田, 健., 伊藤, 俊., & 隈元, 庸. (2005) · Journal of the Japanese Physical Therapy Association
Ziegler, R., & Schwabe, U. (2007) · Springer eBooks · doi:10.1007/978-3-540-34370-7_44
Ziegler, R., & Schwabe, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-72548-0_44
Ahmadi, S. (2024) · Clinical Thyroidology · doi:10.1089/ct.2024;36.47-50
Perros, P. (2024) · Copernicus books · doi:10.1007/978-3-031-58287-5_6
Escobar-Morreale, H. F., Botella-Carretero, J. I., Gómez-Bueno, M. F., Galán, J., Barrios, V., Sancho, J., & Marinò, M. (2006) · L Endocrinologo · doi:10.1007/bf03344541
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2024) · Figshare · doi:10.6084/m9.figshare.26613242
Meiser, E. (2007) · FreiDok plus (Universitätsbibliothek Freiburg)
Sundman, E. (2020) · Helda - University of Helsinki Institutional Repository
Wang, Y., Zhu, J., Li, Z., Yu, F., Fu, Y., Gao, H., Wang, M., Yuan, L., Zheng, L., & He, Q. (2026) · Cell Transplantation · doi:10.1177/09636897261418754
Kumar, R., Pazdernik, V. K., Stan, M. N., Sundaresh, V., Frye, M. A., & Singh, B. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121526
Lora, G. J. T. (2007) · Universidad Industrial de Santander
Additional treatment strategies for hypothyroidism: a network meta-analysis
Lv, X., Qin, W., Li, J., & Likun, D. (2026) · Endocrine Connections · doi:10.1530/ec-26-0011
Singh, A., Jangir, R. K., & Singh, J. (2021) · International Journal of Health and Clinical Research
Metadata
- Authors
- Appelhof, B. C., Fliers, E., Wekking, E. M., Schene, A. H., Huyser, J., Tijssen, J. G. P., Endert, E., van Weert, H. C. P. M., & Wiersinga, W. M.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Appelhof, Bente C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05
- Volume
- 90
- Issue
- 5
- Pages
- 2666-2674
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140933987
- Cited by
- 183
- References
- 30
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 9 · 2018: 13 · 2017: 7 · 2016: 13 · 2015: 7 · 2014: 7 · 2013: 5 · 2012: 11
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- primary hypothyroidism, levothyroxine, liothyronine, T3/T4 ratio, thyroid-stimulating hormone, treatment satisfaction, body weight, fatigue, mood, neurocognitive function, autoimmune hypothyroidism, patient preferences, TSH suppression
- MeSH terms
- Adolescent, Adult, Aged, Cognition, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypothyroidism, Male, Middle Aged, Thyrotropin, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.